Intelligent Implants, a Sweden-based MedTech startup, founded with a vision to transform orthopedic implants, proudly announces the successful closing of its Series A first tranche. The total capital in the first tranche is €6,2M (including conversion of convertible debt). This marks a significant milestone in its journey to revolutionize orthopedic implants.
Intelligent Implants Series A first tranche round was supported by both new and existing investors, highlighting strong investor confidence and interest in the company’s innovative approach to revolutionizing the orthopedic implant market.
“We are very grateful for the support from both existing and new investors that share our excitement for Intelligent Implants’ technology.” said Martin Larsson, Chief Executive Officer and Co-Founder of Intelligent Implants. “Our brilliant team can now initiate activities to take SmartFuse through a first clinical study (15-20 patients), the by far most value adding activity to date!”
The round was supported by new investors, including TB-Gruppen Invest, several prominent orthopedic surgeons and industry professionals with participation from prior investors such as SOSV, SMAI and Axilium.
“We have followed Intelligent Implants for a long time and been impressed with the team and the progress they have made. Their innovative technology has the potential to significantly impact patient outcomes,” said Marcus Lerander, CEO of TB-Gruppen Invest.
“The team has made remarkable progress in developing this novel revolutionary technology of a electrostimulation system that can be incorporated into the small spine implants we use every day and, in the future, many other implants that can help our patients.,” said Rory K.J. Murphy, MD, Co-Founder “By stimulating the bone to grow with the Intelligent Implants electrostimulation implants we believe that we can improve outcomes tremendously for patients who have a hard time to heal following surgery. Combining this with the bone growth sensors has the potential to change the entire industry.”
The funds will be used to accelerate product development and enable Intelligent Implants to advance through its clinical and regulatory plans.
About Intelligent Implants
Intelligent Implants is a medical device company operating at the intersection of digital medicine and orthopedics. Intelligent Implant’s first product, the SmartFuse® System, incorporates the company’s electrotherapeutic technology platform into an intervertebral spacer (SmartFuse CAGE™) with the goal of improving outcomes in lumbar spinal fusion procedures. The implant uses electrical signals and an array of electrodes to accelerate and measure bone growth, while the SmartFuse CLOUD can provide unprecedented visibility into healing with remote data to support real-time clinical decision making. Our team of leading surgeons, engineers, and entrepreneurs is obsessed with developing technologies that raise the bar for physicians and patients alike.
